版本:
中国

BRIEF-Basilea Pharmaceutica ‍announces presentation of interim phase 1/2a clinical data with anticancer drug candidate BAL101553

June 6 BASILEA PHARMACEUTICA AG:

* ‍ANNOUNCES PRESENTATION OF INTERIM PHASE 1/2A CLINICAL DATA WITH ANTICANCER DRUG CANDIDATE BAL101553 AT ASCO MEETING​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准: 汤森路透“信任原则

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐